ClearPoint Neuro Stockholders Approve Key Proposals and Directors

ClearPoint Neuro (CLPT) has shared an update.

At ClearPoint Neuro, Inc.’s Annual Meeting, stockholders cast their votes on key proposals, leading to the re-election of eight directors and the ratification of Cherry Bekaert LLP as the independent accounting firm for the upcoming year. Additionally, an advisory approval of executive compensation was agreed upon, and the Fifth Amended and Restated 2013 Incentive Compensation Plan was approved, setting the stage for the company’s strategic incentive approach for the future.

Learn more about CLPT stock on TipRanks’ Stock Analysis page.